Company news

Zhejiang Medicine Co., Ltd. news in 2025

Zhejiang Medicine Co., Ltd.'s news releases, calls and decks from 2025, newest first.

View company

Announcement on Progress in Change of Share Nature and Progress in Share Granting under 2025 Restricted Stock Incentive Plan

December 30, 2025

Announcement on Granting Restricted Stocks to Incentive Objects of 2025 Restricted Stock Incentive Plan

November 26, 2025

Self-Inspection Report on the Trading of Company's Stock by Information Insiders in 2025 Restricted Stock Incentive Plan

November 13, 2025

Publicity Description and Verification Opinions of the Remuneration and Appraisal Committee of the Board of Directors on the List of Incentive Objects in the 2025 Restricted Stock Incentive Plan

November 7, 2025

Abstract of 2025 Restricted Stock Incentive Plan (Draft)

October 27, 2025

Announcement on Convening the 2025 Semi-annual Performance Briefing

September 10, 2025

2025 Semi-annual Report

August 25, 2025

Announcement on XC2309 Injection Obtaining Notice of Approval for Drug Clinical Trial

August 21, 2025

Announcement on Implementation Result of Shares Repurchase and Share Changes

August 12, 2025

Announcement on Progress in Repurchasing Shares

August 1, 2025

Announcement on Expected Increase in Semi-annual Performance for 2025

July 14, 2025

Announcement on Shares Repurchased Reaching 1% of the Company's Share Capital and Repurchase Progress

July 1, 2025

Announcement on Election Results of Employee Directors for the 10th Board of Directors

June 25, 2025

Announcement on Subsidiary Xinchang Pharmaceutical Factory Passing On-site Inspection by FDA of the United States

June 9, 2025

Announcement on Using Some Idle Self-owned Funds for Entrusted Wealth Management

May 30, 2025

Announcement on Initially Repurchasing the Company's Shares through Call Auction

May 12, 2025

Announcement on Convening the 2024 Annual Performance Briefing

May 8, 2025

Announcement on Resolution of the 5th Meeting of the 10th Board of Directors

April 23, 2025

Announcement on Obtaining Commitment Letter for Share Repurchase Loans from Financial Institutions

April 16, 2025

Announcement on Plan for Repurchasing Shares through Call Auction

April 14, 2025

Indicative Announcement on Proposal of Chairman to Repurchase Shares

April 9, 2025

Announcement on the Shareholding Reduction Plan for Shareholders Holding More than 5% of Shares through Call Auction

March 20, 2025

Announcement on Obtaining Drug Registration Certificate for Compound Sodium Acetate Ringer's Injection

February 27, 2025

Announcement on the Subsidiary Zhejiang Novus Pharmaceuticals Co., Ltd. Passing On-site Inspection by FDA

February 26, 2025

Announcement on Expected Increase in Annual Performance for 2024

January 22, 2025